Expression and significance of HIF-1α and HIF-2α in pancreatic cancer

Abstract

The expression levels of hypoxia-inducible factor 1alpha (HIF-1α) and HIF-2α in pancreatic cancer (PC) and their association with clinicopathologic characteristics were investigated in order to elucidate their roles in the development of PC. HIF-1α and HIF-2α mRNA levels in 20 patients with PC were detected by quantitative real-time polymerase chain reaction. The expression of HIF-1α and HIF-2α protein in samples from other 90 patients with PC was measured by immunohistochemistry. Correlations between the expression of HIF-1α or HIF-2α and clinicopathologica features and prognosis were analyzed. The expression of both HIF-1α and HIF-2α mRNA was up-regulated in most cancer tissues (P<0.05). HIF-1α staining was weakly positive in most cancer tissues and strongly positive in adjacent pancreas tissues (P<0.05). Clinicopathologic analysis revealed that relatively strong HIF-1α expression in cancer tissues was related to greater invasion (P<0.05), higher tumor pathologic stage (P<0.05), higher American Joint Committee on Cancer (AJCC) stage (P<0.05) and shorter overall survival time (P<0.05). Conversely, HIF-2α staining was strongly positive in most cancer tissues and weakly positive in adjacent pancreas tissues. Clinicopathologic analysis revealed that relatively strong HIF-2α expression in cancer tissues was related to less invasion (P<0.05), lower tumor pathologic stage (P<0.05), lower AJCC stage (P<0.05) and longer overall survival time (P<0.05). Moreover, the HIF-1α^high/HIF-2α^low group showed a shorter survival time than the HIF-1α^low/HIF-2α^high group. In conclusion, although HIF-1α and HIF-2α mRNA expression patterns are the same, their protein expression patterns are significantly different and they play different roles in PC. Combined analysis of HIF-1α and HIF-2α expression might be useful to predict the prognosis of patients with PC.

Keywords

pancreatic cancer / HIF-1α / HIF-2α / aggressiveness / prognosis

References

[1] SiegelRL, MillerKD, JemalA. Cancer statistics, 2015. CA Cancer J Clin, 2015, 65(1): 5-29 PMID: 25559415

[2] MegibowAJ. Pancreatic adenocarcinoma: designing the examination to evaluate the clinical questions. Radiology, 1992, 183(2): 297-303 PMID: 1561324

[3] KoongAC, MehtaVK, LeQT, et al. . Pancreatic tumors show high levels of hypoxia. Int J Radia Oncol Biol Physics, 2000, 48(4): 919-922

[4] AravalliRN, CressmanEN, SteerCJ. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol, 2013, 87(2): 227-247 PMID: 23007558

[5] SemenzaGL. Regulation of mammalian O₂ homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol, 1999, 15: 551-578 PMID: 10611972

[6] WengerRH, StiehlDP, CamenischG. Integration of oxygen signaling at the consensus HRE. Sci STKE, 2005, 2005(306): re12 PMID: 16234508

[7] HaaseVH. The VHL tumor suppressor: master regulator of HIF. Curr Pharm Des, 2009, 15(33): 3895-3903 PMCID: 3622710 PMID: 19671042

[8] MajmundarAJ, WongW S MC. Hypoxia inducible factors and the response to hypoxic stress. Mol Cell Endocrinol, 2010, 40(2): 294-309

[9] SemenzaGL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci, 2012, 33(4): 207-214 PMCID: 3437546 PMID: 22398146

[10] KitadaT, SekiS, SakaguchiH, et al. . Clinicopathological significance of hypoxia-inducible factor-1alpha expression in human pancreatic carcinoma. Histopathology, 2003, 43(6): 550-555 PMID: 14636255

[11] MiyakeK, YoshizumiT, ImuraS, et al. . Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas, 2008, 36(3): 1-9

[12] ShibajiT, NagaoM, IkedaN, et al. . Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res, 2003, 23(6C): 4721-4727 PMID: 14981919

[13] SunHC, QiuZJ, LiuJ, et al. . Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol, 2007, 30(6): 1359-1367 PMID: 17487356

[14] ZhaoX, GaoS, RenH, et al. . Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res, 2014, 74(9): 2455-2464 PMID: 24599125

[15] HuCJ, WangLY, ChodoshLA, et al. . Differential roles of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in hypoxic gene regulation. Mol Cell Biol, 2003, 23(24): 9361-9374 PMCID: 309606 PMID: 14645546

[16] WangV, DavisDA, HaqueM, et al. . Differential gene up-regulation by hypoxia-inducible factor-1A and hypoxia-inducible factor-2A in HEK293T cells. Am Assoc Cancer Res, 2005, 65(8): 3299-3306

[17] HuCJ, IyerS, SataurA, et al. . Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol, 2006, 26(9): 3514-3526 PMCID: 1447431 PMID: 16611993

[18] WarneckeC, ZaborowskaZ, KurreckJ, et al. . Differentiating the functional role of hypoxia-inducible factor (HIF)-1a and HIF-2a (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2a target gene in Hep3B and Kelly cells. FASEB J, 2004, 18(12): 1462-1464 PMID: 15240563

[19] CarrollVA, AshcroftM. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res, 2006, 66(12): 6264-6270 PMID: 16778202

[20] SowterHM, RavalRR, MooreJW, et al. . Predominant role of hypoxia-inducible transcription factor(Hif)-1a versus Hif-2a in regulation of the transcriptional response to hypoxia. Cancer Res, 2003, 63(19): 6130-6134 PMID: 14559790

[21] ImamuraT, KikuchiH, HerraizMT, et al. . HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer, 2009, 124(4): 763-771 PMCID: 2682346 PMID: 19030186

[22] UnruhA, ResselA, MohamedHG, et al. . The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene, 2003, 22(21): 3213-3220 PMID: 12761491

[23] GriffithsEA, PritchardSA, ValentineHR, et al. . Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer, 2007, 96(1): 95-103 PMCID: 2360219 PMID: 17179985

[24] BangouraG, LiuZS, QianQ, et al. . Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol, 2007, 13(23): 3176-3182 PMCID: 4436602 PMID: 17589895

[25] SunHX, XuY, YangXR, et al. . Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/E2F transcription factor 1-dependent apoptotic pathway. Hepatology, 2013, 57(3): 1088-1097 PMCID: 3594482 PMID: 23212661

[26] YangSL, LiuLP, JiangJX, et al. . The correlation of expression levels of HIF-1alpha and HIF-2alpha in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients’clinical outcome. Jpn J Clin Oncol, 2014, 44(2): 159-167 PMID: 24374892

[27] KeithB, JohnsonRS, SimonMC. HIF1a and HIF2a: sibling rivalry in hypoxic tumor growth and progression. Nat Rev Cancer, 2012, 12(1): 9-22

[28] HaraS, HamadaJ, KobayashiC, et al. . Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Commun, 2001, 287(4): 808-813 PMID: 11573933

[29] ZhangP, YaoQ, LuL, et al. . Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia. Cell Reports, 2014, 6(6): 1110-1121 PMID: 24613356